Showing 23,074 news articles about PEP

Filters Content type: Editors' picks Topic: PEP

Post-exposure prophylaxis involves taking a 28-day course of anti-HIV drugs, after possible exposure to HIV. It may be used by healthcare workers (occupational PEP) or after sex (post-exposure prophylaxis after sexual exposure, PEPSE, also known as non-occupational PEP or nPEP).

Harm reduction

Fiji: Experts push harm reduction plan to curb HIV

Editor's pick
FBC News
15 April 2026
Injectable & long-acting PrEP

One Million More People to Get HIV ‘Miracle’ Drug Lenacapavir as US, Global Fund Expand Access

Editor's pick
Health Policy Watch
15 April 2026
Low CD4 count

Mpox Can Infect And Replicate In The Brain, NIH Researchers Say In Fatal HIV Case

Editor's pick
NDTV
15 April 2026
The search for a cure

Norwegian effectively cured of HIV after transplant from brother

Editor's pick
France 24
15 April 2026
Health services & systems

‘I’m serving my people’: The pastor running a rural South African clinic that treats more than illness

Editor's pick
Spotlight
16 April 2026
Government, leadership & policy

‘Vought cuts kill people’: Aids activists interrupt Trump budget chief hearing

Editor's pick
The Guardian
16 April 2026
Ageing & HIV

Why Chronic Inflammation Drives Multimorbidity in People With HIV, Despite Viral Suppression

Editor's pick
TheBodyPro
16 April 2026
Global health initiatives

New PEPFAR Data Show Worrying Declines in Testing and Treatment for H.I.V.

Editor's pick
The New York Times (requires free registration)
20 April 2026
New & experimental HIV treatments

FDA Approves Merck’s Once-Daily IDVYNSO™ (doravirine/islatravir)

Editor's pick
Merck press release
21 April 2026
Global health initiatives

PEPFAR data shows drops in HIV prevention as US claims success

Editor's pick
Devex (requires free registration)
23 April 2026
Harm reduction

“Blaming Down”: A Decade of Overdose Crisis in British Columbia

Editor's pick
Filter
23 April 2026
Migrants, refugees & displaced people

Latin America: Access to HIV Care for migrants hindered by exclusionary policies

Editor's pick
HIV Justice Network
23 April 2026
Global health initiatives

Researchers Dispute US Government’s Upbeat Data About PEPFAR’s Impact on HIV

Editor's pick
Health Policy Watch
23 April 2026
HIV testing programmes & uptake

One in three young women in Africa have never tested for HIV – new study shows where the gaps lie

Editor's pick
The Conversation
23 April 2026
The search for a cure

HIV Cure Research Advances by Important Steps (but No Leaps)

Editor's pick
TheBodyPro
23 April 2026
HIV testing policies & guidelines

One-in-three Russians should be tested for HIV every year, urges health minister

Editor's pick
The Telegraph
23 April 2026
Injectable & long-acting PrEP

Only three new HIV cases on lenacapavir PrEP: updates from PURPOSE-1 and -2

Editor's pick
i-Base
23 April 2026
Ageing & HIV

HIV treatment reduces accelerated biological ageing by nearly four years, landmark study shows

Editor's pick
EurekAlert!
23 April 2026
New & experimental HIV treatments

Newly Approved HIV Treatment Option Is No More Than Fine — and Shows Just How Good HIV Treatment Is Today

Editor's pick
Paul Sax (NEJM Voices)
24 April 2026
Access to healthcare

Florida ADAP Cuts Leave Thousands of Floridians With HIV Facing a Drug Coverage Cliff

Editor's pick
TheBody
24 April 2026
HIV & criminal law

UK: Rapist who infected men and boys with HIV jailed

Editor's pick
BBC News
24 April 2026
Condoms & lubricant

World's biggest condom maker set to raise prices due to Iran war

Editor's pick
BBC News
24 April 2026
Injectable & long-acting PrEP

Who controls South Africa’s lenacapavir rollout? Not South Africa

Editor's pick
Health-E News
24 April 2026
Finance & funding

Aid cuts and a failed deal: Zimbabwe’s frontline health care under strain

Editor's pick
Devex (requires free registration)
27 April 2026